We regret to inform you that the publisher of this article, American Chemical Society, has removed this article from DeepDyve.

Occasionally, journals transition between publishers. This article may be available on DeepDyve from the journal's new publisher.

Find the current version of this article on DeepDyve

Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β‑Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa
Dhiman, Shiv; Ramirez, Danyel; Li, Yanqi; Kumar, Ayush; Arthur, Gilbert; Schweizer, Frank ACS Infectious Diseases.
Find this article